Covista screens attractively valued at a forward P/E of 13.2 times and a PEG of 0.88, underpinned by four consecutive earnings beats averaging more than 11% above consensus; the chief offset is negative price momentum that has not cleared the minimum threshold, keeping the entry setup cautious despite sound fundamentals.
Thesis pillars
- Negative Momentum Near Term Headwind↑Improving
- Attractive Forward Valuation Low Peg↑Improving
- Solid Piotroski Financial Health→Stable
- +1 more pillar — see the Why tab for full reasoning
Pillars as of Jul 3, 2026, based on the 10-K filed Aug 6, 2026· older than 90 days
Covista Inc. (CVSA) Stock Analysis
Consumer Defensive · Education & Training Services
Hold if already holding. Not a fresh buy at $124.19, but acceptable to hold if already in. Reasons: Thin upside margin: 8.8%; Negative momentum.
Covista is America's largest healthcare educator, serving 100,000 students and supported by an alumni network of 400,000 across five accredited institutions: Chamberlain University ("Chamberlain"), Walden University ("Walden"), American University of the Caribbean School of... Read more
Hold if already holding. Not a fresh buy at $124.19, but acceptable to hold if already in. Reasons: Thin upside margin: 8.8%; Negative momentum. Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Score 5.9/10, moderate confidence.
Passes 6/8 gates (clean insider activity, no SEC red flags, news events none recent, earnings proximity 84d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: aggressive.
Recent developments
updated Nov 3, 2026Recent Developments — Covista Inc.
Latest news
- NEWS Covista (CVSA) Stock Could Be Undervalued As Cash Flow Stays Strong - Simply Wall St — Simply Wall St Nov 3, 2026 positive
- NEWS Covista (CVSA) Stock Drops Despite Strong Q1 Earnings - Simply Wall St — Simply Wall St Oct 31, 2026 neutral
- NEWS Covista Inc. Reports Fiscal Q1 2027 Results, Raises Outlook, and Announces CFO Retirement — fiscal.ai Oct 29, 2026 neutral
- NEWS Earnings to watch: Covista (CVSA) reports Q3 results tomorrow - Yahoo Finance — Yahoo Finance Oct 28, 2026 neutral
- NEWS Earnings to watch: Covista (CVSA) reports Q3 results tomorrow - TradingView — TradingView Oct 28, 2026 neutral
Latest item Nov 3, 2026 · Generated 2026-11-05T11:39:29Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Momentum below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $124.19, but acceptable to hold if already in. Reasons: Thin upside margin: 8.8%; Negative momentum. Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Analyst target $135.15 (+8.8%), stop $115.50 (−7.5%), A.R:R 1.1:1. Score 5.9/10, moderate confidence.
Analyst target: $135.15 (+8.8% upside). Analyst target $135.15 (+8.8%), stop $115.50 (−7.5%), A.R:R 1.1:1. Stop-loss: $115.50.
Thin upside margin: 8.8%; Negative momentum.
Covista Inc. trades at a P/E of 15.7 (forward 12.3). TrendMatrix value score: 7.5/10. Verdict: Hold.
10 analysts rate CVSA, with a consensus score of 4.2/5. 4 analysts publish price targets averaging $159.
What does Covista Inc. do?Covista is America's largest healthcare educator, serving 100,000 students and supported by an alumni network of...
Covista is America's largest healthcare educator, serving 100,000 students and supported by an alumni network of 400,000 across five accredited institutions: Chamberlain University ("Chamberlain"), Walden University ("Walden"), American University of the Caribbean School of Medicine ("AUC"), Ross University School of Medicine ("RUSM"), and Ross University School of Veterinary Medicine ("RUSVM"). Covista delivers education to its students at multiple campuses and online.